| 2024-12-11 | Caloric value of food stuff | 0:00 | 1 | |
|
| 2024-12-11 | Classification of lipids | 0:00 | 0 | |
|
| 2024-12-11 | Donovanosis | 0:00 | 0 | |
|
| 2024-12-11 | Congenital prenatal syphilis | 0:00 | 1 | |
|
| 2024-12-11 | Physiological changes in aging - part 2 | 0:00 | 0 | |
|
| 2024-12-11 | Alopecia areata | 0:00 | 2 | |
|
| 2024-12-11 | Physiological changes in aging - part 1 | 0:00 | 0 | |
|
| 2024-12-11 | Late congenital syphilis - Clinical features | 0:00 | 1 | |
|
| 2024-12-11 | Allergic contact dermatitis , photoallergic dermatitis - Diagnostic test | 0:00 | 0 | |
|
| 2024-12-11 | Syphilis | 0:00 | 3 | |
|
| 2024-12-09 | Darriers disease | 0:00 | 2 | |
|
| 2024-12-09 | Psoriatic nails vs onchomycosis | 0:00 | 4 | |
|
| 2024-12-09 | Therapeutic drug monitoring - part 3 | 0:00 | 2 | |
|
| 2024-12-08 | Hailey Hailey disease | 0:00 | 3 | |
|
| 2024-12-08 | Dermatitis herpetiformis | 0:00 | 0 | |
|
| 2024-12-08 | Bullous pemphigoid | 0:00 | 3 | |
|
| 2024-12-08 | Trichotillomaia | 0:00 | 0 | |
|
| 2024-12-08 | Psoariasis signs | 0:00 | 3 | |
|
| 2024-12-08 | Hair and stages | 0:00 | 0 | |
|
| 2024-12-08 | Structures passing through skull foramina - Part 2 | 0:00 | 2 | |
|
| 2024-12-07 | Immunoflourescece in dermatology | 0:00 | 0 | |
|
| 2024-12-07 | Lichen nitidus | 0:00 | 1 | |
|
| 2024-12-07 | Lichen planus | 0:00 | 0 | |
|
| 2024-12-07 | Blistering skin lesions | 0:00 | 2 | |
|
| 2024-12-07 | Epidermolysis bullous | 0:00 | 1 | |
|
| 2024-12-07 | Pure neuritis Hansen | 0:00 | 2 | |
|
| 2024-12-06 | Types of collagen | 0:00 | 0 | |
|
| 2024-12-06 | Leprosy multidrug therapy - Treatment | 0:00 | 1 | |
|
| 2024-12-06 | Na + K + Sodium potassium ATPase pump | 0:00 | 0 | |
|
| 2024-12-06 | Cutaneous TB Management | 0:00 | 7 | |
|
| 2024-12-06 | Layers of epidermis | 0:00 | 5 | |
|
| 2024-12-06 | Secondary skin lesions | 0:00 | 0 | |
|
| 2024-12-04 | Acne vulgaris - Part 2 | 0:00 | 2 | |
|
| 2024-12-04 | Acne vulgaris | 0:00 | 5 | |
|
| 2024-12-04 | Acne vulgaris - part 3 | 0:00 | 4 | |
|
| 2024-11-16 | Regulation of growth hormone secretion | 0:00 | 1 | |
|
| 2024-11-16 | Vitamin D | 0:00 | 1 | |
|
| 2024-11-16 | SGLT , GLUT transporter part 2 | 0:00 | 0 | |
|
| 2024-11-16 | PTH - Parathyroid hormone | 0:00 | 1 | |
|
| 2024-11-15 | Sacral plexus - part 2 | 0:00 | 6 | |
|
| 2024-11-15 | Drug effect modification - part 3 | 0:00 | 2 | |
|
| 2024-11-15 | Temporomandibular Joint TMJ | 0:00 | 3 | |
|
| 2024-11-15 | Conns syndrome | 0:00 | 1 | |
|
| 2024-11-15 | Sacral plexus | 0:00 | 2 | |
|
| 2024-11-15 | Receptor binding - part 3 | 0:00 | 0 | |
|
| 2024-11-15 | Types of cartilages | 0:00 | 1 | |
|
| 2024-10-28 | Physiological changes of aging - part 2 | 0:00 | 3 | |
|
| 2024-10-28 | Ribosomal assembly - prokaryotes | 0:00 | 4 | |
|
| 2024-10-28 | Drugs in therapeutic drug monitoring - part 2 | 0:00 | 0 | |
|
| 2024-10-28 | Types of enzyme inducers | 0:00 | 1 | |
|
| 2024-10-28 | Physiological changes of aging - part 1 | 0:00 | 0 | |
|
| 2024-10-28 | NA + K + Sodium potassium ATPase pump | 0:00 | 0 | |
|
| 2024-10-27 | Prolactin | 0:00 | 1 | |
|
| 2024-10-27 | Regulators of pyrimidine synthesis | 0:00 | 0 | |
|
| 2024-10-24 | Regulators of pyramidine synthesis | 0:00 | 3 | |
|
| 2024-10-24 | Bursitis | 0:00 | 1 | |
|
| 2024-10-24 | Localisation of human genes | 0:00 | 1 | |
|
| 2024-10-24 | Arteries of cranial fossa | 0:00 | 1 | |
|
| 2024-10-24 | COX 2 | 0:00 | 1 | |
|
| 2024-10-24 | Caloric value of food stuff | 0:00 | 2 | |
|
| 2024-10-24 | Sites of various pathways in cell | 0:00 | 1 | |
|
| 2024-10-24 | Composition of oil | 0:00 | 1 | |
|
| 2024-10-23 | Classification of lipids | 0:00 | 3 | |
|
| 2024-10-23 | Localisation of human genes - part 2 | 0:00 | 3 | |
|
| 2024-10-22 | COX 1 | 0:00 | 2 | |
|
| 2024-10-22 | Cmax and AUC | 0:00 | 1 | |
|
| 2024-10-22 | Types of enzyme - part 2 | 0:00 | 3 | |
|
| 2024-10-22 | Types of enzyme inducers - Part 1 | 0:00 | 1 | |
|
| 2024-10-22 | COX 2 | 0:00 | 1 | |
|
| 2024-10-22 | Beta oxidation of fatty acids | 0:00 | 1 | |
|
| 2024-10-21 | Biosynthesis of fatty acids | 0:00 | 3 | |
|
| 2024-10-21 | Components of oil | 0:00 | 4 | |
|
| 2024-10-21 | Ketogenesis | 0:00 | 3 | |
|
| 2024-10-21 | Sites of various pathways of cell | 0:00 | 1 | |
|
| 2024-10-21 | Receptor binding - par 2 | 0:00 | 0 | |
|
| 2024-10-21 | Fixed dose combination - part 2 | 0:00 | 0 | |
|
| 2024-10-21 | Drug effect modifications- part 2 | 0:00 | 0 | |
|
| 2024-10-19 | Therapeutic index - part 2 | 0:00 | 0 | |
|
| 2024-10-19 | CYP 2c8 and CYP 2c9 | 0:00 | 0 | |
|
| 2024-10-19 | Drug effect modulations - part 1 | 0:00 | 0 | |
|
| 2024-10-19 | Non dialyzable drugs | 0:00 | 1 | |
|
| 2024-10-19 | Prolactin - part 2 | 0:00 | 0 | |
|
| 2024-10-19 | Conns syndrome | 0:00 | 0 | |
|
| 2024-10-19 | Prolactin | 0:00 | 0 | |
|
| 2024-10-19 | SGLT and GLUT transporter | 0:00 | 0 | |
|
| 2024-10-19 | Factors increasing insulin secretion | 0:00 | 1 | |
|
| 2024-10-19 | Arteries of anterior cranial fossa | 0:00 | 0 | |
|
| 2024-10-19 | Types of enzyme inducers | 0:00 | 0 | |
|
| 2024-10-19 | Vitamin D | 0:00 | 0 | |
|
| 2024-10-19 | Distribution of coronary artery | 0:00 | 0 | |
|
| 2024-10-19 | Drugs of therapeutic drug monitoring | 0:00 | 2 | |
|
| 2024-10-19 | Dialyzable drugs - part 1 | 0:00 | 1 | |
|
| 2024-10-19 | Ph and drug elimination - part 2 | 0:00 | 1 | |
|
| 2024-10-19 | Therapeutic index - part 3 | 0:00 | 0 | |
|
| 2024-10-19 | Drugs of therapeutic drug monitoring - part 2 | 0:00 | 1 | |
|
| 2024-10-19 | Drug and prodrug | 0:00 | 1 | |
|
| 2024-10-19 | Renal excretion | 0:00 | 1 | |
|
| 2024-10-19 | Bursitis | 0:00 | 0 | |
|
| 2024-10-19 | Gluteal region and muscles | 0:00 | 0 | |
|
| 2024-10-19 | Structures passing through skull foramina | 0:00 | 3 | |
|
